#United States #New York #TheGrossLawFirm #PepGenInc #PEPG

Important Notice for PepGen Inc. Shareholders

On June 12, 2025, The Gross Law Firm announced a critical alert for shareholders of PepGen Inc., trading under the NASDAQ symbol PEPG. Those who acquired shares during a specified timeframe starting from March 7, 2024, to March 3, 2025, are strongly encouraged to contact the law firm. This call to action aims to facilitate a discussion regarding potential claims concerning misleading statements made by the company during this class period.

Allegations Against PepGen Inc.

The allegations outlined in the complaint suggest that during the class period, PepGen's leadership may have misled investors by providing inaccurate information about its lead product candidate, PGN-EDO51. Specifically, it was alleged that the company's representatives stated that PGN-EDO51 was both effective and safe, a claim that is now called into question as more information has come to light. Additionally, the CONNECT2 study, a phase two clinical trial, has come under scrutiny for alleged safety concerns and its adequacy for FDA approval.

As these issues surfaced, concerns grew that PepGen might discontinue its CONNECT2 study or face significant setbacks, suggesting that the prospects for PGN-EDO51 in clinical, regulatory, and commercial terms were significantly overstated. These revelations have led to the conclusion that the company's public statements over this key period were potentially misleading and raise various legal concerns.

Upcoming Deadline and Next Steps

Shareholders should take immediate action and not delay in registering for this class action. The deadline for seeking to be appointed as a lead plaintiff in this case is August 8, 2025. Registering as a shareholder affected by these issues will allow participants to be enrolled in a monitoring software designed to keep them informed about developments in their case throughout its duration.

For affected shareholders, participation in this case involves no financial obligation, providing a risk-free opportunity to pursue justice. Interested parties can sign up by visiting the dedicated section on The Gross Law Firm's website, where they can submit their information.

Why Choose The Gross Law Firm?

The Gross Law Firm has established a reputation as a renowned class action litigation firm committed to protecting investors' rights. They strive to hold companies accountable for any fraudulent practices and ensure that corporate governance is maintained effectively. By standing up to deceitful practices, the firm aims to secure compensation for investors who have faced losses due to misrepresentation or omission of critical information by companies like PepGen.

For additional inquiries, shareholders are encouraged to contact The Gross Law Firm directly:

• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Phone: (646) 453-8903
• - Email: Email Contact

Act now to protect your rights as an investor and ensure that you are fully informed of your options within this legal context.